OPRX vs. NICE
OPRX (OptimizeRx Corporation) and NICE (NICE Ltd.) are both stocks. OPRX operates in Health Information Services (Healthcare), while NICE operates in Software - Application (Technology). Over the past 10 years, OPRX returned 18.64%/yr vs 4.49%/yr for NICE. At a 0.13 correlation, their price movements are largely independent.
Performance
OPRX vs. NICE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, OPRX achieves a -47.72% return, which is significantly lower than NICE's -11.77% return. Over the past 10 years, OPRX has outperformed NICE with an annualized return of 18.64%, while NICE has yielded a comparatively lower 4.49% annualized return.
OPRX
- 1D
- 2.07%
- 1M
- 21.40%
- 6M
- -51.29%
- YTD
- -47.72%
- 1Y
- -49.53%
- 3Y*
- -24.61%
- 5Y*
- -35.05%
- 10Y*
- 18.64%
NICE
- 1D
- 1.92%
- 1M
- 13.24%
- 6M
- -14.80%
- YTD
- -11.77%
- 1Y
- -35.59%
- 3Y*
- -21.22%
- 5Y*
- -17.19%
- 10Y*
- 4.49%
OPRX vs. NICE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
OPRX OptimizeRx Corporation | -47.72% | 152.26% | -66.04% | -14.82% | -72.95% | 99.33% | 203.41% | -6.38% | 598.73% | 93.83% |
NICE NICE Ltd. | -11.77% | -33.44% | -14.87% | 3.75% | -36.66% | 7.07% | 82.75% | 43.38% | 17.73% | 33.92% |
Correlation
The correlation between OPRX and NICE is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.24 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.25 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.32 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.24 |
Correlation (All Time) Calculated using the full available price history since Jul 13, 2007 | 0.13 |
The correlation between OPRX and NICE shifts across timeframes, from 0.13 (all time) to 0.32 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
OPRX:
$120.28M
NICE:
$5.84B
OPRX:
$0.36
NICE:
$8.52
OPRX:
17.87
NICE:
11.70
OPRX:
0.03
NICE:
0.35
OPRX:
1.14
NICE:
2.06
OPRX:
0.93
NICE:
1.64
OPRX:
$107.35M
NICE:
$3.01B
OPRX:
$70.86M
NICE:
$1.98B
OPRX:
$16.55M
NICE:
$841.27M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
OPRX vs. NICE — Risk / Return Rank
OPRX
NICE
OPRX vs. NICE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for OptimizeRx Corporation (OPRX) and NICE Ltd. (NICE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| OPRX | NICE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.10 | ||
| Sortino ratioReturn per unit of downside risk | +0.12 | ||
| Omega ratioGain probability vs. loss probability | 0.91 | 0.87 | +0.04 |
| Calmar ratioReturn relative to maximum drawdown | -0.66 | -0.76 | +0.10 |
| Martin ratioReturn relative to average drawdown | -1.04 | -1.20 | +0.16 |
Loading charts...
Drawdowns
OPRX vs. NICE - Drawdown Comparison
The maximum OPRX drawdown since its inception was -99.32%, which is greater than NICE's maximum drawdown of -93.23%. Use the drawdown chart below to compare losses from any high point for OPRX and NICE.
Loading charts...
Drawdown Indicators
| OPRX | NICE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.32% | -93.23% | -6.09% |
Max Drawdown (1Y)Largest decline over 1 year | -79.06% | -51.19% | -27.87% |
Max Drawdown (3Y)Largest decline over 3 years | -79.06% | -68.21% | -10.85% |
Max Drawdown (5Y)Largest decline over 5 years | -96.10% | -73.60% | -22.50% |
Max Drawdown (10Y)Largest decline over 10 years | -96.10% | -73.60% | -22.50% |
Current DrawdownCurrent decline from peak | -93.46% | -68.34% | -25.12% |
Average DrawdownAverage peak-to-trough decline | -60.69% | -35.27% | -25.42% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 49.95% | 32.47% | +17.48% |
Volatility
OPRX vs. NICE - Volatility Comparison
OptimizeRx Corporation (OPRX) has a higher volatility of 15.60% compared to NICE Ltd. (NICE) at 10.16%. This indicates that OPRX's price experiences larger fluctuations and is considered to be riskier than NICE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| OPRX | NICE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.60% | 10.16% | +5.44% |
Volatility (6M)Calculated over the trailing 6-month period | 54.82% | 42.52% | +12.30% |
Volatility (1Y)Calculated over the trailing 1-year period | 79.01% | 51.48% | +27.53% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 76.06% | 39.92% | +36.14% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 114.59% | 33.27% | +81.32% |
Dividends
OPRX vs. NICE - Dividend Comparison
Neither OPRX nor NICE has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NICE NICE Ltd. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.14% | 0.76% | 0.91% |
OPRX OptimizeRx Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
OPRX vs. NICE - Financials Comparison
This section allows you to compare key financial metrics between OptimizeRx Corporation and NICE Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
OPRX vs. NICE - Profitability Comparison
OPRX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, OptimizeRx Corporation reported a gross profit of 14.93M and revenue of 19.84M. Therefore, the gross margin over that period was 75.3%.
NICE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, NICE Ltd. reported a gross profit of 493.46M and revenue of 766.53M. Therefore, the gross margin over that period was 64.4%.
OPRX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, OptimizeRx Corporation reported an operating income of 396.00K and revenue of 19.84M, resulting in an operating margin of 2.0%.
NICE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, NICE Ltd. reported an operating income of 126.41M and revenue of 766.53M, resulting in an operating margin of 16.5%.
OPRX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, OptimizeRx Corporation reported a net income of -495.00K and revenue of 19.84M, resulting in a net margin of -2.5%.
NICE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, NICE Ltd. reported a net income of 46.69M and revenue of 766.53M, resulting in a net margin of 6.1%.
Frequently Asked Questions
OPRX and NICE have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
OPRX has higher volatility (15.60%) compared to NICE (10.16%). In terms of maximum drawdown, OPRX dropped -99.32% vs NICE's -93.23%.
OPRX currently has the higher Sharpe Ratio (-0.66 vs -0.76), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for OPRX and NICE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer